NewsDesk  @infectiousdiseasenews Pfizer Inc. and BioNTech SE today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention...

With the nation focused on the delivery of a COVID vaccine, the CDC wants to ensure that older individuals are protected against other prevalent yet preventable diseases that can lead to severe health...

From the Infectious Diseases Society of America (IDSA): People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according...

One week after Canadian officials approved GlaxoSmithKline’s shingles vaccine, Shingrix, the US Food and Drug Administration (FDA) gave the vaccine it’s approval. The FDA on Friday approved...

GlaxoSmithKline  announced this week that it has submitted a Biologics License Application (BLA) for its candidate shingles vaccine, ShingrixTM, to the United States Food and Drug Administration (FDA),...

GlaxoSmithKline (GSK) announced the publication of detailed results from a randomized phase III study (ZOE-70) of its investigational shingles vaccine, showing 90% efficacy in adults aged 70 years and...

According to a report originated in the National Center for Immunization and Respiratory Diseases, infection with varicella zoster virus (VZV) causes two distinct clinical conditions. Primary VZV infection...